|
人VEGFR2 / KDR / CD309 HEK293过表达细胞系 Human VEGFR2 / KDR / CD309 HEK293 Cell Line
靶点信息

Target: Kinase insert domain receptor Alias: CD309, FLK1, VEGFR, VEGFR2
KDR(激酶插入结构域受体)是一种在血管内皮细胞上高表达的受体酪氨酸激酶,作为VEGF的主要信号传导受体,通过激活下游MAPK、PI3K/AKT等通路调控血管生成、血管通透性和内皮细胞存活。 |
产品信息
人VEGFR2 / KDR / CD309 NF-AT-HEK293过表达细胞系是一种重组细胞系,经工程化改造后可稳定表达细胞表面人 VEGFR2 蛋白,并携带 NF-AT 报告基因系统,广泛用于机制研究、高通量筛选、药物靶标验证及其他相关领域。
| Host Cell | HEK293 | Gene | VEGFR2 / KDR / CD309 | | Size | >5x10^6 cells per vial | Storage | Liquid nitrogen | | Species | Human | Shipment | Dry Ice | | Stability | Validated for at least 10 passages | | Quality Control | Negative for bacteria, yeast, fungi and mycoplasma. | | Applications | Widely used in mechanisms study, high-throughput screening, drug target validation and others. | | Revival | After retrieving the cells from the liquid nitrogen tank, rapidly thaw them in a 37°C water bath. Transfer contents into a tube with pre-warmed media. Centrifuge cells and seed into a 25 cm^2 flask containing pre-warmed media. |

产品验证

备注:图片仅供参考,具体验证数据以购买时交付批次为准
|